Product news from the 03/27/07 news brief
The FDA has approved UCB's anti-epileptic drug Keppra (levetiracetam), as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.